Cargando…
Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children
Excessive drooling may complicate the care of children with chronic neurological conditions by socially isolating both patients and families and by causing secondary dermatitis and infection. Normal control of saliva requires normal integrity of oral structures, normal oropharyngeal sensation, and m...
Autor principal: | Evatt, Marian L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191867/ https://www.ncbi.nlm.nih.gov/pubmed/22003294 http://dx.doi.org/10.2147/NDT.S14028 |
Ejemplares similares
-
Glycopyrrolate for drooling in children with medical complexity under three years of age
por: Lovardi, Eleonora, et al.
Publicado: (2022) -
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions
por: Zeller, Robert S, et al.
Publicado: (2012) -
Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions
por: Zeller, Robert S, et al.
Publicado: (2012) -
Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience
por: Zanon, Davide, et al.
Publicado: (2021) -
Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus
por: Riva, Antonella, et al.
Publicado: (2022)